FrankSCapriottiJBrownSM, et al. Povidone-iodine use in sinonasal and oral cavities: a review of safety in the COVID-19 era. Ear Nose Throat J2020; 99(9): 586–593.
3.
KhanMMParabSRParanjapeM.Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol2020; 41(5): 102618.
4.
ManaguttiAManaguttiSAPatelJ, et al. Evaluation of post-surgical bacteremia with use of povidone-iodine and chlorhexidine during mandibular third molar surgery. J Maxillofac Oral Surg2017; 16(4): 485–490.
5.
SatomuraKKitamuraTKawamuraT, et al. Prevention of upper respiratory tract infections by gargling: a randomized trial. Am J Prev Med2005; 29(4): 302–307.
6.
XiaJTongJLiuM, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol2020; 92(6): 589–594.
7.
ColavitaFLapaDCarlettiF, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med2020; 173(3): 242–243.
8.
LoonSCTeohSCOonLL, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol2004; 88(7): 861–863.
9.
WuPDuanFLuoC, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol2020; 138(5): 575–578.
10.
KariwaHFujiiNTakashimaI.Inactivation of SARS Coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology2006; 212(Suppl. 1): 119–123.
11.
PeposeJSAhujaALiuW, et al. Randomized, controlled, phase 2 trial of povidone-iodine/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol2018; 194: 7–15.
12.
QuirogaLPLansinghVLaspinaF, et al. A prospective study demonstrating the effect of 5% povidone-iodine application for anterior segment intraocular surgery in Paraguay. Arq Bras Oftalmol2010; 73(2): 125–128.
13.
NakashizukaHShimadaHHattoriT, et al. Vitrectomy using 0.025% povidone-iodine in balanced salt solution plus for the treatment of postoperative endophthalmitis. Retina2015; 35(6): 1087–1094.
14.
OtaniKShimadaH.Capsular bag irrigation using 0.025% povidone-iodine in balanced salt solution PLUS for the treatment of postoperative endophthalmitis. Int Ophthalmol2018; 38(6): 2267–2268.
15.
KoshyZRDickieD.Aerosol generation from high speed ophthalmic instrumentation and the risk of contamination from SARS COVID19. Eye2020; 34(11): 1954–1955.
16.
ZhangSJLiuPLiM, et al. Preliminary observation of domestic 5% povidone-iodine on the antibacterial effect of the conjunctival sac and the influence of corneal epithelium before cataract extraction. Zhonghua Yan Ke Za Zhi2019; 55(7): 509–514.
17.
YanaiRYamadaNUedaK, et al. Evaluation of povidone-iodine as a disinfectant solution for contact lenses: antimicrobial activity and cytotoxicity for corneal epithelial cells. Cont Lens Anterior Eye2006; 29(2): 85–91.
18.
KoernerJCGeorgeMJMeyerDR, et al. Povidone-iodine concentration and dosing in cataract surgery. Surv Ophthalmol2018; 63(6): 862–868.
19.
ShimadaHAraiSNakashizukaH, et al. Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone–iodine. Am J Ophthalmol2011; 151(1): 11–17.
20.
PelsEVrensenGF.Microbial decontamination of human donor eyes with povidone-iodine: penetration, toxicity, and effectiveness. Br J Ophthalmol1999; 83(9): 1019–1026.
